Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas R De Ridder
Thomas R De Ridder
Medicine
Tigilanol tiglate
Mast cell tumors
Concomitant
clinical study
4
Papers
18
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate
2021
Journal of Veterinary Internal Medicine
Paul Reddell
Thomas R De Ridder
John M. Morton
Pamela D. Jones
Justine E Campbell
Graham Brown
Chad M. Johannes
Peter F. Schmidt
Victoria A. Gordon
Show All
Source
Cite
Save
Citations (2)
Intratumoural Treatment of 18 Cytologically Diagnosed Canine High-Grade Mast Cell Tumours With Tigilanol Tiglate.
2021
Frontiers in Veterinary Science
Graham Brown
Justine E Campbell
Pamela D. Jones
Thomas R De Ridder
Paul Reddell
Chad M. Johannes
Show All
Source
Cite
Save
Citations (0)
Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC-46).
2020
Journal of Veterinary Internal Medicine
Thomas R De Ridder
Justine Emma Campbell
Cheryl Burke-Schwarz
David Clegg
Emily L Elliot
Samuel Geller
Wendy Kozak
Stephen T. Pittenger
Jennifer B Pruitt
Jocelyn Riehl
Julie White
Melissa L Wiest
Chad M. Johannes
John Morton
Pamela D. Jones
Peter Frederick Schmidt
Victoria A. Gordon
Paul Reddell
Show All
Source
Cite
Save
Citations (13)
Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
2020
Frontiers in Veterinary Science
Thomas R De Ridder
Mick Ruppin
Meagan Wheeless
Stephanie Williams
Paul Reddell
Show All
Source
Cite
Save
Citations (3)
1